Aster DM Healthcare will Treat Public Well with its IPO

New Delhi/ Dubai:Aster DM Healthcare, a private healthcare provider major, operating in vast swathe of UAE and India, launched its IPO (Initial Public Offering) today with much fan fare. Its shares are up for grab till Thursday (January 15). On a robust growth path, the company is likely to gross more than it has bargained for.

Its motto as a health provider has been ‘we will treat you well’. It is very likely that it will treat public well with IPO too. The scrip is listed on both BSE and NSE.

The price band has been set @Rs 180-190 per share with a face value of Rs 10 each. The company has issued a total number of 51,586,146 equity shares (including fresh issue of 38,157,895 shares and offer for sale of 13,428,251 shares).

At the upper end of the price band, the IPO is expected to mop up Rs 980.13 crore. Proceeds of the issue will be used towards repayment of debt, purchase of medical equipment, and for other general corporate purposes.

Incorporated in 1987, Aster DM Healthcare Ltd is Kochi, Kerala based healthcare service provider with operations in GCC states (United Arab Emirates, Oman, Saudi Arabia, Qatar, Kuwait and Bahrain), India and the Philippines.

Aster DM Healthcare has its operations in a number of sectors of the healthcare industry including hospitals, clinics and retail pharmacies. Company operates hospitals and clinics, pharmacies, diagnostic centres, educational institutions, and healthcare management and healthcare support systems. Company provides healthcare services to patients across economic segments under brand names including ‘Aster’, ‘Medcare’ and ‘Access’.

Aster’s healthcare facilities consist of 9 hospitals, 90 clinics and 206 retail pharmacies in the GCC states, 10 multi-specialty hospitals and 7 clinics in India, and 1 clinic in the Philippines as of September 30, 2017. Aster’s had 17,408 employees as of September 30, 2017, including 1,417 full time doctors, 5,797 nurses, 1,752 paramedics and 8,442 other employees (including pharmacists).

Aster’s hospitals in India are located in Kochi, Kolhapur, Kozhikode, Kottakkal, Bengaluru, Vijayawada, Guntur, Wayanad and Hyderabad and are generally operated under the Aster, MIMS, Ramesh and Prime brands.

Dr Azad Moopen, its promoter and chairman, Aster DM Healthcare is Padmashri awardee, the highest civilian award, in his home country India and has the reputation of being a great philanthropist.

  • Related Posts

    Medicines that cure Us are making Our Environment Sick

    Antimicrobial Resistance Campaigner makes a Fervent Appeal for Safe Disposal of Leftover Medicines New Delhi: We invariably worry about what might be the side effects of medicines on our body…

    ZEN- G packs a punch in Organ Donation as Over 500 Students pledge Organs

    National Organ Transplant Games2026 set World Record in Talkatora Indoor Stadium New Delhi: The National Organ Transplant Games began on a high note in Talkatora Indoor Stadium on November 1,…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Cancer drug prices to fall by up to 96% from November 9; consumers set to save Rs 3,502 crore annually

    Cancer drug prices to fall by up to 96% from November 9; consumers set to save Rs 3,502 crore annually

    Nigeria’s Anti-Narcotics Agency Uncovers Drug Shipments Concealed In Sofas, Snacks, Detergents And Women’s Headwear

    Nigeria’s Anti-Narcotics Agency Uncovers Drug Shipments Concealed In Sofas, Snacks, Detergents And Women’s Headwear

    FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

    FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

    Stents to syringes: Serious harm reports surge, but makers remain unnamed

    Stents to syringes: Serious harm reports surge, but makers remain unnamed

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru